Showing results (421-430 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|July 1, 1989
The logical structure and validity of experimental designs in pharmacokinetics and clinical pharmacologyE J Mason, M BialerBiopharmaceutics & Drug Disposition|November 29, 2013
ABCB1 haplotype influences the sirolimus dose requirements in Chinese renal transplant recipientsJun Lee, Hongfeng Huang, Ying Chen, et al.Biopharmaceutics & Drug Disposition|November 29, 2013
Quercetin-3-rhamnoglucoside (rutin) stimulates transport of organic anion compounds mediated by organic anion transporting polypeptide 2B1Jiro Ogura, Takahiro Koizumi, Masahiro Segawa, et al.Biopharmaceutics & Drug Disposition|November 29, 2013
Transport characteristics and transporter-based drug-drug interactions of TM-25659, a novel TAZ modulatorMin-Koo Choi, Mihwa Kwon, Jin Hee Ahn, et al.Biopharmaceutics & Drug Disposition|December 11, 2013
Enantioselective disposition of clenbuterol in ratsIori Hirosawa, Mai Ishikawa, Mio Ogino, et al.Biopharmaceutics & Drug Disposition|August 27, 2014
Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancersTakeo Nakanishi, Ikumi TamaiBiopharmaceutics & Drug Disposition|August 25, 2015
Kidney function changes with aging in adults: comparison between cross-sectional and longitudinal data analyses in renal function assessmentSang M Chung, David J Lee, Austin Hand, et al.Biopharmaceutics & Drug Disposition|December 3, 2014
In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450sJeongmin Joo, Zhexue Wu, Boram Lee, et al.Biopharmaceutics & Drug Disposition|March 1, 1986
Brain uptake of labelled adiphenine in ratsJ Michelot, M F Moreau, A Veyre, et al.Biopharmaceutics & Drug Disposition|May 20, 2016
The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic ratsYousef A Bin Jardan, Dion R BrocksPageof 214